The Influences of Early Mobilization on Myokines, Body Composition and Outcomes in ICU Septic Patients
Primary Purpose
Sepsis
Status
Recruiting
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
early mobilization (physical therapy)
Sponsored by
About this trial
This is an interventional supportive care trial for Sepsis focused on measuring sepsis, early mobilization, myokines, body composition
Eligibility Criteria
Inclusion Criteria: 1. Aadmission in ICU 2. Clinical diagnosis of sepsis Exclusion Criteria: 1. Expired in 3-days 2. Cardiac stents or pacemakers 3. Airborne disease 4. Contact-transmitted disease
Sites / Locations
- Kaohsiung Chang Gung Memorial HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Experimental
Experimental
Arm Label
non-PT group
Early-PT group
Delayed-PT
Arm Description
with no physical treatment intervention (group 1)
with physical treatment intervention started in ICU admission day 3 (group 2)
with physical treatment intervention started after ICU admission day 3 (group 3)
Outcomes
Primary Outcome Measures
ICU mortality
Status of survival or mortality at the time discharged from ICU
Hospital mortality
Status of survival or mortality at the time discharged from hospital
7-day mortality
Status of survival or mortality at Day 7 during hospital stay
28-day mortality
Status of survival or mortality at Day 28 during hospital stay
90-day mortality
Status of survival or mortality at Day 90 during hospital stay
ICU Days
length of ICU stay
Change of white blood cell between day 1 and day 8
assessing the change of white blood cell count between day 1 and day 8
Ventilation days
Total using days of mechanical ventilation
Change of percentage of body fat between day 1 and day 8
assessing the change of percentage of body fat between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)
Change of total body water between day 1 and day 8
assessing the change of total body water between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)
Change of soft lean mass between day 1 and day 8
assessing the change of soft lean mass between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)
Concentration of serum IL-6 change between day 1 and day 8
assessing the change of IL-6 between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Concentration of serum BDNF change between day 1 and day 8
assessing the change of serum BDNF between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Concentration of serum IL-15 change between day 1 and day 8
assessing the change of serum IL-15 between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Concentration of serum SPARC change between day 1 and day 8
assessing the change of serum SPARC (secreted protein acidic and rich in cysteine) between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Concentration of serum Irisin change between day 1 and day 8
assessing the change of serum Irisin between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Concentration of serum Myostatin change between day 1 and day 8
assessing the change of serum Myostatin between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Secondary Outcome Measures
Full Information
NCT ID
NCT06061224
First Posted
September 5, 2023
Last Updated
September 24, 2023
Sponsor
Chang Gung Memorial Hospital
1. Study Identification
Unique Protocol Identification Number
NCT06061224
Brief Title
The Influences of Early Mobilization on Myokines, Body Composition and Outcomes in ICU Septic Patients
Official Title
The Influences of Duration and Intensity of Early Mobilization on Myokines, Body Composition and Outcomes of Septic Patients in Intensive Care Unit
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2022 (Actual)
Primary Completion Date
June 30, 2025 (Anticipated)
Study Completion Date
September 30, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chang Gung Memorial Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
the investigators' preliminary data revealed that early physical therapy in patients with sepsis in ICU could promote recovery of function (liver and kidney) and decrease the length of stay in hospitalization. The levels of plasma IL-6 and IL-10 were higher in non-survival group than in survival group. the investigators hypothesize that myokines and body composition parameters are related to the prognosis of sepsis.the investigators will investigate the influences of duration and intensity of early mobilization on myokines, body composition and outcomes of septic patients in intensive care. The proposed study can help precision medicine in the future.
Detailed Description
The septic patients admitted to the intensive care unit (ICU) will be divided into three groups. One is non-PT group, with no physical treatment intervention (group 1), Early-PT group with physical treatment intervention started in ICU admission day 3 (group 2), and Delayed-PT with physical treatment intervention started after ICU admission day 3 (group 3). The grouping will be based on clinical indication for early mobilization (physical therapy) as below. The body composition data (of day 1, 3, 8) of the patients in the three groups will be measured, and the residual blood from day 1 and day 8 will be collected for detecting myokines.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sepsis
Keywords
sepsis, early mobilization, myokines, body composition
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
600 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
non-PT group
Arm Type
No Intervention
Arm Description
with no physical treatment intervention (group 1)
Arm Title
Early-PT group
Arm Type
Experimental
Arm Description
with physical treatment intervention started in ICU admission day 3 (group 2)
Arm Title
Delayed-PT
Arm Type
Experimental
Arm Description
with physical treatment intervention started after ICU admission day 3 (group 3)
Intervention Type
Behavioral
Intervention Name(s)
early mobilization (physical therapy)
Intervention Description
The investigators will consult rehabilitation department for Physical Therapy and patients will be grouped as clinically allocation.
Protocols for consideration of initiation The timing is 72 hours after admission to ICU, early mobilization doses and duration is as the protocol of rehabilitation department
Primary Outcome Measure Information:
Title
ICU mortality
Description
Status of survival or mortality at the time discharged from ICU
Time Frame
The day discharged from ICU, "through study completion, an average of 1 year".
Title
Hospital mortality
Description
Status of survival or mortality at the time discharged from hospital
Time Frame
The day discharged from hospital, "through study completion, an average of 1 year".
Title
7-day mortality
Description
Status of survival or mortality at Day 7 during hospital stay
Time Frame
Day 7 after hospital admission
Title
28-day mortality
Description
Status of survival or mortality at Day 28 during hospital stay
Time Frame
Day 28 after hospital admission
Title
90-day mortality
Description
Status of survival or mortality at Day 90 during hospital stay
Time Frame
Day 90 after hospital admission
Title
ICU Days
Description
length of ICU stay
Time Frame
During hospitalization, "through study completion, an average of 1 year".
Title
Change of white blood cell between day 1 and day 8
Description
assessing the change of white blood cell count between day 1 and day 8
Time Frame
Day 1 and Day8 after ICU admission
Title
Ventilation days
Description
Total using days of mechanical ventilation
Time Frame
During hospitalization, "through study completion, an average of 1 year".
Title
Change of percentage of body fat between day 1 and day 8
Description
assessing the change of percentage of body fat between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)
Time Frame
Day 1 and Day 8 after ICU admission
Title
Change of total body water between day 1 and day 8
Description
assessing the change of total body water between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)
Time Frame
Day 1 and Day 8 after ICU admission
Title
Change of soft lean mass between day 1 and day 8
Description
assessing the change of soft lean mass between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)
Time Frame
Day 1 and Day 8 after ICU admission
Title
Concentration of serum IL-6 change between day 1 and day 8
Description
assessing the change of IL-6 between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Time Frame
Day 1 and Day 8 after ICU admission
Title
Concentration of serum BDNF change between day 1 and day 8
Description
assessing the change of serum BDNF between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Time Frame
Day 1 and Day 8 after ICU admission
Title
Concentration of serum IL-15 change between day 1 and day 8
Description
assessing the change of serum IL-15 between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Time Frame
Day 1 and Day 8 after ICU admission
Title
Concentration of serum SPARC change between day 1 and day 8
Description
assessing the change of serum SPARC (secreted protein acidic and rich in cysteine) between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Time Frame
Day 1 and Day 8 after ICU admission
Title
Concentration of serum Irisin change between day 1 and day 8
Description
assessing the change of serum Irisin between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Time Frame
Day 1 and Day 8 after ICU admission
Title
Concentration of serum Myostatin change between day 1 and day 8
Description
assessing the change of serum Myostatin between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)
Time Frame
Day 1 and Day 8 after ICU admission
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
1. Aadmission in ICU 2. Clinical diagnosis of sepsis
Exclusion Criteria:
1. Expired in 3-days 2. Cardiac stents or pacemakers 3. Airborne disease 4. Contact-transmitted disease
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
FANG WEN-FENG
Phone
+886 7 731 7123
Ext
8775
Email
wenfengfang@yahoo.com.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
FANG WEN-FENG
Organizational Affiliation
Chang Gung Memorial Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaohsiung Chang Gung Memorial Hospital
City
Kaohsiung City
ZIP/Postal Code
83301
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
WEN-FENG Fang
Phone
+886 7 731 7123
Ext
8775
Email
wenfengfang@yahoo.com.tw
12. IPD Sharing Statement
Learn more about this trial
The Influences of Early Mobilization on Myokines, Body Composition and Outcomes in ICU Septic Patients
We'll reach out to this number within 24 hrs